Impact of a charitable medication program and social vulnerability index on clinical outcomes in uninsured adults with diabetes

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to assess how charitable medication programs affect clinical outcomes and the role of social vulnerability in follow-up practices.
Retrospective chart review of uninsured adults with type 2 diabetes receiving medication from a specific program.
Clinical outcomes were measured at baseline and after six months.
Social vulnerability index was assessed for each patient.
Significant reductions in HbA1c from 11.30% to 9.60% and blood pressure within six months.
Other outcomes like low-density lipoprotein and body mass index improved but were not statistically significant.
Higher social vulnerability index was associated with patients lacking follow-up HbA1c tests.

We only have this paper's title and publication details.

Retrospective chart review evaluates clinical outcomes in uninsured adults with diabetes, suggesting improved health with medication programs.

No takes yet. Share an insight, caveat, or question.

Walter et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share